“Our framework was designed to help patients and physicians decide when to stop taking even safe and effective drugs in situations that are often radically different from those where the medications were started.”
“One of those patients was more than 100 years old, quite frail, with advanced cancer and multiple other medical problems. The other one was dead. It made us wonder whether something wasn't missing from those guidelines.”
